Automatic Data Processing Inc
Change company Symbol lookup
Select an option...
ADP Automatic Data Processing Inc
ATLO Ames National Corp
AGMH AGM Group Holdings Inc
DXLG Destination XL Group Inc
CENQ Cenaq Energy Corp
SJIJ South Jersey Industries Inc
CVS CVS Health Corp
HRTG Heritage Insurance Holdings Inc
ESUS ETRACS 2x Leveraged MSCI USA ESG Focus TR ETN
BSRR Sierra Bancorp
Go

Information Technology : IT Services | Large Cap Blend
Company profile

Automatic Data Processing, Inc. (ADP) is a global technology company engaged in providing cloud-based human capital management (HCM) solutions that unite HR, payroll, talent, time, tax and benefits administration. Its segments include Employer Services and Professional Employer Organization (PEO). Its Employer Services segment serves clients ranging from single-employee small businesses to large enterprises with tens of thousands of employees around the world, offering a range of technology-based HCM solutions, including its cloud-based platforms, and human resource outsourcing (HRO) solutions (other than PEO) solutions. Its offerings include Payroll Services, Benefits Administration, Talent Management, HR Management, Workforce Management, Compliance Services, Insurance Services and Retirement Services. Its PEO business, called ADP TotalSource, provides clients with employment administration outsourcing solutions. It serves over 990,000 clients in 140 countries and territories.

Closing Price
$226.19
Day's Change
-1.56 (-0.68%)
Bid
--
Ask
--
B/A Size
--
Day's High
229.69
Day's Low
225.94
Volume
(Heavy Day)
Volume:
2,875,272

10-day average volume:
1,986,562
2,875,272

Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish

8:45 am ET July 27, 2022 (BusinessWire) Print

Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of the Dexcom G6 mobile app in Spanish, available immediately for users with a compatible iOS (v1.10.1) or Android (v1.10.0) smart device.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220727005109/en/

Diabetes disproportionately impacts Latinos, and as of 2022, it is estimated that 11.8% of U.S. Latino adults have diagnosed diabetes.(1) Furthermore, the CDC estimates that U.S. Latino adults have more than a 50% chance of developing Type 2 diabetes, with a greater risk of complication.(2)

"With a myriad of studies that point to language barriers in healthcare leading to miscommunication between patients and healthcare providers(3) and a decrease in quality of care and patient safety, it's important to provide access to diabetes information in a patient's preferred language to improve health outcomes," said Ana-Mari Calleja Carr, district business manager at Dexcom representing the South Florida region. "Launching the Dexcom G6 app in Spanish is a positive step toward improving health equity for individuals with diabetes who primarily speak Spanish."

To access the Dexcom G6 mobile app in Spanish, users need to install the latest version of the app and set their compatible iOS (v1.10.1) or Android (v1.10.0) smartphone* language to Spanish (any dialect/region). The app will automatically display in Spanish as long as the phone language is set to Spanish.

"Being able to offer this powerful CGM technology to my Spanish-speaking patients in their preferred language can help them better understand their diabetes and be more proactive about managing their health," said Dr. Rocio Harbison, MD, FACE, an endocrinologist who treats a large Spanish-speaking population. "CGM technology is one of the most powerful tools available for managing diabetes and this new development from Dexcom will help improve access for Spanish-speaking people who often have to navigate their health with limited Spanish-language tools."

Dexcom G6 uses a small, wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a compatible smart device* or receiver, giving patients real-time glucose data without the need to prick their finger.+ The system also offers customizable alerts and alarms to help avoid potentially dangerous low and high blood sugar events.

"It's great to see that Dexcom invested in developing a Spanish-language app for patients," said Siena Ruelas, a professional soccer player and Dexcom Warrior who has Type 1 diabetes. "This offering will help remove a significant barrier to accessing important glucose information and improve one's ability to make critical health decisions."

The Dexcom Follow app is not immediately available in Spanish but the functionality will be added in a future product update. For more information in Spanish on Dexcom G6, please visit Dexcom.com/ayuda.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

*For a list of compatible devices, visit www.dexcom.com/compatibility.

+If your glucose alerts and readings from the G6 do not match symptoms or expectations or you're taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions.

(1) https://www.diabetes.org/about-us/statistics/about-diabetes (2) https://www.cdc.gov/diabetes/library/features/hispanic-diabetes.html (3)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201401/

(C) 2022 Dexcom, Inc. Dexcom, Dexcom G6 and Dexcom Follow are registered trademarks of DexCom, Inc. in the U.S., and may be registered in other countries. All rights reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005109/en/

SOURCE: Dexcom, Inc.

Media Contact 
James McIntosh
619-884-2118
james.mcintosh@dexcom.com

Investor Contact 
Sean Christensen
858-203-6657
sean.christensen@dexcom.com
comtex tracking

COMTEX_411071059/1006/2022-07-27T08:45:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.